Vitamin C Enhances Chemosensitization of Esophageal Cancer Cells in Vitro

References

• Pera M, Cameron A, Trastek V, Carpenter H, Zermeister A. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993; 104: 510–513.
   PubMed Web of Science ®Google Scholar
• Aldulaimi D, Jankowski J. Barrett's oesophagus: an overview of the molecular biology. Dis Oesophegus 1999; 12: 177–180.
   PubMed Web of Science ®Google Scholar
• Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodel therapy and surgery for oesophageal adenocarcinoma. New Engl J Med 1996; 335: 462–468.
   PubMed Web of Science ®Google Scholar
• Kelsen DP, Ginsberg R, Pajak TF et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998; 339: 1979–84.
   PubMed Web of Science ®Google Scholar
• Ansfield FJ, Greenspan EM. 5-Fluorouracil for gastroin-testinal cancer. N Engl J Med 1979; 301: 328–329.
   PubMed Web of Science ®Google Scholar
• Sugamura K, Makino M, Shirai H et al. Enhanced induction of apoptosis of human gastric carcinoma cells after preoperative treatment with 5-fluorouracil. Cancer 1997; 79: 12–17.
   Google Scholar
• Wadler S, Horowitz R, Zhang HY, Schwartz EL. Effects of perturbations of pools of deoxyribonucleoside triphosphates on expression of ribonucleotide reductase, a Gl/S transition state enzyme, in p53-mutated cells. Biochem Pharmacol 1998; 55: 1353-1360.
   Google Scholar
• Ohtani T, Hatori M, Ito H, Takizawa K, Kamijo R, Nagumo M. Involvement of caspases in 5-FU induced apopto-sis in an oral cancer cell line. Anticancer Res 2000; 20: 3117-3121.
   Google Scholar
• Kashani S, Lu Y, Leong L, Haedicke K, Scanlon J. Differential oncogene amplification in tumor cells from a patient treated with cisplatin and 5-fluorouracil. Eur J Cancer 1990; 26: 383–390.
   PubMed Web of Science ®Google Scholar
• Zaffaroni N, Silvestrini R, Orlandi L, Bearzatto A, Gornati D, Villa R. Induction of apoptosis by taxol and cis-platin and effect on cell cycle-related proteins in cisplatin-sen-sitive and -resistant human ovarian cells. Br J Cancer 1998; 77: 1378–1385.
   PubMed Web of Science ®Google Scholar
• Young MR, Yang HS, Colburn NH. Promising molecu-lar targets for cancer prevention: AP-1, NF-kappa B and Pdcd4. Trends Mol Med 2003; 9: 36–41.
   PubMed Web of Science ®Google Scholar
• Hsu TC, Young MR, Cmarik J, Colburn NH. Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis. Free Radic Biol Med 2000; 28: 1338-1348.
   Google Scholar
• Wang C, Cusak JC, Liu R, Baldwin AS. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-KB. Nat Med 1999; 5: 412–417.
   PubMed Web of Science ®Google Scholar
• Wang C-Y, Mayo MW, Baldwin AS. TNF-a and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kB. Science 1996; 274: 784–787.
   PubMed Web of Science ®Google Scholar
• Urn JH, Kang CD, Lee BC, Kim DW, Chung BS, Kim SH. Increased and correlated nuclear factor-kappa B and Ku autoantigen activities are associated with development of mul-tidrug resistance. Oncogene 2001; 20: 6048–6056.
   PubMed Web of Science ®Google Scholar
• Daschner PJ, Ciolino HP, Plouzek CA, Yeh GC. Increased AP-1 activity in drug resistant human breast cancer MCF-7 cells. Breast Cancer Res Treat 1999; 53: 229–240.
   PubMed Web of Science ®Google Scholar
• Abdel-Latif MM, O'Riordan J, Windle HJ et al. JV. NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy. Ann Surg 2004; 239: 491–500.
   Google Scholar
• Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 1996; 10: 709–720.
   PubMed Web of Science ®Google Scholar
• Bowie A, O'Neill LA. Oxidative stress and nuclear fac-tor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 2000; 59: 13–23.
   PubMed Web of Science ®Google Scholar
• Kopp EB, Ghosh S. NF-KB and Rel proteins in innate immunity. Adv Immunol 1995; 58: 1–27.
   PubMed Web of Science ®Google Scholar
• Baeuerle PA, Henkel T. Function and activation of NF-KB in the immune system. Annu Rev Immunol 1994; 12: 141–179.
   PubMed Web of Science ®Google Scholar
• Frei B. Reactive oxygen species and antioxidant vita-mins: Mechanism of action. Am J Med 1994; 97: 5S-13S.
   Google Scholar
• Mirvish SS. Effects of vitamin C and E on N-nitroso compound formation, carcinogenesis, and cancer. Cancer 1986; 58 (Suppl 8):1842–1850.
   PubMed Web of Science ®Google Scholar
• Fountoulakis A, Martin IG, White KL et al. Plasma and esophageal mucosal levels of vitamin C: role in the pathogen-esis and neoplastic progression of Barrett's esophagus. Dig Dis Sci 2004; 49: 914–919.
   PubMed Web of Science ®Google Scholar
• Kurbacher CM, Wagner U, Kolster B, Andreotti PE, Krebs D, Bruckner HW. Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and pacli-taxel in human breast carcinoma cells in vitro. Cancer Lett 1996; 103: 183–189.
   PubMed Web of Science ®Google Scholar
• Nagy B, Mucsi I, Molnar J, Varga A, Thurzo L. Chemosensitizing effect of vitamin C in combination with 5-fluorouracil in vitro. In Vivo 2003; 17: 289–92
   PubMed Web of Science ®Google Scholar
• Reddy VG, Khanna N, Singh N. Vitamin C augments chemotherapeutic response of cervical carcinoma HeLa cells by stabilizing p53. Biochem Biophys Res Commun 2001; 282: 409–415.
   PubMed Web of Science ®Google Scholar
• Conklin KA. Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer 2000; 37: 1–18
   PubMed Web of Science ®Google Scholar
• Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 297: 680–685.
   Web of Science ®Google Scholar
• Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor alpha and interleukin-1 stimulate the human immunodeficicen-cy virus enhancer by activation of the nuclear factor kappa B. Pro Natl Acad Sci USA 1989; 86: 2336-2340.
   Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1979; 72: 248–254.
   Web of Science ®Google Scholar
• Uddin S, Ahmad S. Antioxidant protection against can-cer and other human diseases. Comprehen Therap 1995; 21: 41–45.
   PubMedGoogle Scholar
• Block G. Vitamin C and cancer prevention: the epi-demiological evidence. Am J Nutr 1991; 53: 270S-282S.
   Google Scholar
• Lee KW, Lee HJ, Surh YJ, Lee CY. Vitamin C and cancer chemoprevention: reappraisal. Am J Clin Nutr 2003; 78: 1074–1078.
   PubMed Web of Science ®Google Scholar
• Head KA. Ascorbic acid in the prevention and treat-ment of cancer. Altern Med Rev 1998; 3: 174–186.
   PubMedGoogle Scholar
• Park CH, Kimler BF. Growth modulation of human leukemic, pre-leukemic and myeloma progenitor cell by L-ascorbic acid. Am J Clin Nutr 1991; 54: 1241S-1246S.
   Google Scholar
• Murakami K, Muto N, Fukasawa GK, Yamamoto I. Comparison of ascorbic acid and ascorbic acid 2-0-L-glucosi-dase on the cytotoxicity and bioavailability to low density cul-ture of fibroblast. Biochem Pharmacol 1992; 44: 2191-2197.
   Google Scholar
• Roomi MW, House D, Eckert-Maksic M, Maksic ZB, Tsao CS. Growth suppression of malignant leukemia cell line in vitro by ascorbic acid (Vitamin C) and its derivatives. Cancer Lett 1998; 122: 93–99.
   PubMed Web of Science ®Google Scholar
• Pavelic K. L-ascorbic acid induced DNA strand breaks and cross links in human neuroblastoma cell. Brain Res 1985; 342: 369–373.
   PubMed Web of Science ®Google Scholar
• Medina MA, de Veas RG, Schweigerer L. Ascorbic acid is cytotoxic for peidoatric tumor cells cultured in vitro. Biochem Mol Biol Inter 1994; 34: 871–874.
   PubMedGoogle Scholar
• Bowie AG, O'Neill LAJ. Vitamin C inhibits NF-KB acti-vation by TNF via the activation of p38 mitogen-activated pro-tein kinase. J Immunol 2000; 165: 7180-7188.
   Google Scholar
• Saeed RW, Peng T, Metz CN. Ascorbic acid blocks the growth inhibitory effect of tumor necrosis factor-a on endothelial cells. Exptll Biol Med 2003; 228: 855–865.
   Web of Science ®Google Scholar
• Waring AJ, Drake IM, Schorah CJ, et al. Ascorbic acid and total vitamin C concentrations in plasma, gastric juice, and gastrointestinal mucosa: effects of gastritis and oral sup-plementation. Gut 1996; 38: 171–176.
   PubMed Web of Science ®Google Scholar
• Waring AJ, Schorah CJ. Transport of ascorbic acid in gastric epithelial cells in vitro. Clin Chim Acta 1998; 275: 137–149.
   PubMed Web of Science ®Google Scholar
• Hediger MA. New view at C. Nat Med 2002; 8: 445–446.
   PubMed Web of Science ®Google Scholar